21
Participants
Start Date
April 30, 2013
Primary Completion Date
October 31, 2016
Study Completion Date
October 31, 2016
pazopanib
Treatment with pazopanib 800 mg qd for 21 days followed by resection of the tumor after a 7-14 days break
Klinikum Frankfurt-Höchst, Frankfurt am Main
University Hospital Mannheim, Dpt. of Surgery, Mannheim
German Cancer Research Center, Medical PET Group - Biological Imaging, Heidelberg
University Hospital Heidelberg / National Centre for Tumor Diseases, Heidelberg
Collaborators (1)
Universitätsmedizin Mannheim
OTHER
Klinikum Frankfurt Höchst
OTHER
German Cancer Research Center
OTHER
GlaxoSmithKline
INDUSTRY
University Hospital Heidelberg
OTHER
Heidelberg University
OTHER